Agenda

News

Croda Pharma introduces new bioprocessing solutions to replace banned materials

2 October 2023

Croda Pharma has introduced a critical range of new bioprocessing detergents optimised for viral inactivation and cell lysis. The company’s new product range, Virodex™, offers an answer to the key market need for replacing the popular, but now banned, bioprocessing detergent, Triton™ X-100.

TO KNOW MORE

Dyadic and bYoRNA Announce a Collaboration Targeting the Production of Abundant, Low-Cost mRNA From C1-Cells

2 October 2023

Dyadic & bYoRNA announced that they entered into a development and commercialization agreement to work on disruptive bioproduction technologies that will help exploit the therapeutic potential of mRNA.

TO KNOW MORE

subscribe to our newsletter

Our Board of Directors

Our Members

This is a unique website which will require a more modern browser to work!

Please upgrade today!